<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">36809148</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2165-0497</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>Microbiology spectrum</Title><ISOAbbreviation>Microbiol Spectr</ISOAbbreviation></Journal><ArticleTitle>Antibodies to Nucleocapsid Are Not Diagnostic for Long COVID.</ArticleTitle><Pagination><StartPage>e0490022</StartPage><MedlinePgn>e0490022</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e04900-22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/spectrum.04900-22</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brandt</LastName><ForeName>C T</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Zealand University Hospital, University of Copenhagen, Roskilde, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiese</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Zealand University Hospital, University of Copenhagen, Roskilde, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christiansen</LastName><ForeName>K M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agergaard</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Microbiol Spectr</MedlineTA><NlmUniqueID>101634614</NlmUniqueID><ISSNLinking>2165-0497</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>doi: 10.1128/spectrum.02537-22</RefSource></CommentsCorrections></CommentsCorrectionsList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36809148</ArticleId><ArticleId IdType="pmc">PMC10100955</ArticleId><ArticleId IdType="doi">10.1128/spectrum.04900-22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fogh K, Larsen TG, Hansen CB, Hasselbalch RB, Eriksen ARR, Bundgaard H, Frikke-Schmidt R, Hilsted LM, &#xd8;stergaard L, Johansen IS, Hageman I, Garred P, Iversen K. 2022. Self-reported long COVID and its association with the presence of SARS-CoV-2 antibodies in a Danish cohort up to 12 months after infection. Microbiol Spectr 10:e02537-22. doi:10.1128/spectrum.02537-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.02537-22</ArticleId><ArticleId IdType="pmc">PMC9769646</ArticleId><ArticleId IdType="pubmed">36350150</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Hoogen LL, Smits G, van Hagen CCE, Wong D, Vos ERA, van Boven M, de Melker HE, van Vliet J, Kuijer M, Woudstra L, Wijmenga-Monsuur AJ, GeurtsvanKessel CH, Stoof SP, Reukers D, Wijsman LA, Meijer A, Reusken CBEM, Rots NY, van der Klis FRM, van Binnendijk RS, den Hartog G. 2022. Seropositivity to nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: a complementary tool to detect breakthrough infections after COVID-19 vaccination? Vaccine 40:2251&#x2013;2257. doi:10.1016/j.vaccine.2022.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.03.009</ArticleId><ArticleId IdType="pmc">PMC8904156</ArticleId><ArticleId IdType="pubmed">35287986</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfego D, Sullivan A, Poirier B, Williams J, Adcock D, Letovsky S. 2021. A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States. EClinicalMedicine 36:100902. doi:10.1016/j.eclinm.2021.100902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100902</ArticleId><ArticleId IdType="pmc">PMC8143650</ArticleId><ArticleId IdType="pubmed">34056568</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>